The present invention is directed to radiolabeled pyrimidinone compounds of general structural formula I which are useful as radiotracers for quantitative imaging of PDE10 in mammals.
-
(2019/07/13)
PYRIMIDINONES AS PDE10 INHIBITORS
The present invention is directed to pyrimidinone compounds of general structural formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10).
-
Page/Page column 50-51
(2010/12/26)
More Articles about upstream products of 1256450-66-4
Get Best Price for1256450-66-41H-Isoindole-1,3(2H)-dione,2-[2-[3,4-dihydro-3-(1H-indazol-6-yl)-7-Methyl-4-oxo-2-quinazolinyl]ethyl]-4-(1-Methylethoxy)-